T26

T26 is a medicinal cannabis product developed and marketed by PHCANN International, consisting of standardized dried cannabis flower with a tetrahydrocannabinol (THC) content of approximately 26%. As a botanical product, it contains a complex profile of cannabinoids and terpenes, with THC serving as the primary active constituent. THC acts as a partial agonist at the cannabinoid CB1 and CB2 receptors within the endocannabinoid system, modulating neurotransmitter release to produce analgesic, anti-spastic, and anti-emetic effects. T26 is intended for administration via inhalation, typically through vaporization or smoking, and is used in the management of various conditions including chronic pain, multiple sclerosis-related spasticity, and chemotherapy-induced nausea, subject to regional medicinal cannabis regulations.

Brand names

T26T-26T 26

Other names

PHCANN T26T26 Dried Cannabis FlowerT-26 Dried Cannabis FlowerT 26 Dried Cannabis FlowerPHCANN International T26